These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32948345)

  • 1. Advances in urologic oncology "OncoForum": The best of 2019.
    Gómez-Veiga F; Alcaraz Asensio A; Burgos Revilla J; Cózar Olmo J
    Actas Urol Esp (Engl Ed); 2020 Nov; 44(9):586-596. PubMed ID: 32948345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in urologic oncology «OncoForum»: The best of 2015.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2016; 40(6):361-9. PubMed ID: 27061663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developments in urologic oncology "OncoForum": The best of 2017.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp (Engl Ed); 2018 Oct; 42(8):488-498. PubMed ID: 29935800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in urologic oncology «OncoForum»: The best of 2016.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo JM
    Actas Urol Esp; 2017 Nov; 41(9):543-551. PubMed ID: 28734596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in uro-oncology "OncoForum": the best of 2013.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2014 Oct; 38(8):491-8. PubMed ID: 24731526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in urologic oncology 'OncoForum': The best of 2014.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2015 Jun; 39(5):271-8. PubMed ID: 25770399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in urologic oncology "OncoUrology Forum Special Edition": The best of 2020.
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla JM; Cózar-Olmo FJ
    Actas Urol Esp (Engl Ed); 2022 May; 46(4):214-222. PubMed ID: 34844900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in uro-oncology «Oncoforum»: the best of 2011].
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo J
    Actas Urol Esp; 2012 Oct; 36(9):507-14. PubMed ID: 22520042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights from the 2024 ASCO Genitourinary Symposium: focus on urothelial and prostate cancer.
    Strusi A; Pinterpe G; Ciccarese C; Pedone RR; Sarcina M; Sardaro V; Belletto R; Totaro A; Racioppi M; Berardi R; Tortora G; Iacovelli R
    Expert Rev Anticancer Ther; 2024 Aug; 24(8):661-664. PubMed ID: 38932631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination radiotherapy-immunotherapy in genitourinary cancer].
    Ollivier L; Guimas V; Rio E; Vaugier L; Masson I; Libois V; Labbé M; Fradin D; Potiron V; Supiot S
    Cancer Radiother; 2021 Oct; 25(6-7):565-569. PubMed ID: 34391648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of metastatic, castration-resistant prostate cancer].
    von Amsberg G; Merseburger AS
    Urologe A; 2020 Jun; 59(6):673-679. PubMed ID: 32274540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update urooncology: news with clinical relevance from major scientific meetings 2012].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICUD-EAU International Consultation on Bladder Cancer 2012: Urothelial carcinoma of the prostate.
    Palou J; Wood D; Bochner BH; van der Poel H; Al-Ahmadie HA; Yossepowitch O; Soloway MS; Jenkins LC;
    Eur Urol; 2013 Jan; 63(1):81-7. PubMed ID: 22938869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challenges.
    Solinas C; Chanzá NM; Awada A; Scartozzi M
    Cancer Treat Rev; 2017 Feb; 53():138-145. PubMed ID: 28113097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201).
    Borgmann H; Lallous N; Ozistanbullu D; Beraldi E; Paul N; Dalal K; Fazli L; Haferkamp A; Lejeune P; Cherkasov A; Gleave ME
    Eur Urol; 2018 Jan; 73(1):4-8. PubMed ID: 28851578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in immuno-oncology and its application to urological cancers.
    Mataraza JM; Gotwals P
    BJU Int; 2016 Oct; 118(4):506-14. PubMed ID: 27123757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
    Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.